Month: June 2024

Guillain-Barre Syndrome ‘More Common Than Expected’ In RSV Vaccinated Older Adults: CDC

Guillain-Barré syndrome (GBS) is a rare neurological disorder of concern with the…

admin admin

Gilead Sciences ADC Flunks Its Confirmatory Test in Advanced Bladder Cancer

Gilead Sciences' cancer therapy Trodelvy did not improve overall survival for patients…

admin admin

Enhanced flu vaccines ‘sensitive to price’ in terms of impact

A HIQA report found that switching to enhanced flu vaccines for over-65s…

admin admin

Journalists Talk Cost of Weight Loss Drugs and Lack of Obesity Doctors to Manage Their Use

KFF Health News senior correspondents discussed various health topics such as weight…

admin admin

Heron Therapeutics announces increased net sales in first-quarter 2024 financial results

Heron Therapeutics reported increased net product sales of $34.7 million in the…

admin admin

Letters to First Opinion on caregivers, digital health, and more

The article discusses the importance of evaluating digital therapeutics individually based on…

admin admin

Bird flu: US confirms first case with respiratory symptoms

The US has confirmed its first case of a person with H5N1…

admin admin

Antibody discovery promises new hope in influenza B battle, paves way for universal vaccine

Researchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against…

admin admin

key to reducing heart disease and mortality through epigenetics

A study published in the Journal of the American Heart Association explored…

admin admin

Severe Hypoglycemia in Diabetes Drug Approved in Europe

The European Medicines Agency (EMA) has recommended marketing authorization for Zegalogue (dasiglucagon)…

admin admin
error: Content is protected !!